Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Crit Rev Oncol Hematol ; 189: 104067, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37454703

ABSTRACT

Colorectal cancer (CRC) is the third most common malignant tumor and one of the deadliest cancers. At molecular level, CRC is a heterogeneous disease that could be divided in four Consensus Molecular Subtypes. Given the differences in the disease due to its anatomical location (proximal and distal colon), another classification should be considered. Here, we review the current knowledge on CRC dichotomic´s behaviour based on two different entities; right and left-sided tumors, their impact on clinical trial data, microbiota spatial composition and the interaction with the nervous system. We discuss recent advances in understanding how the spatial tumor heterogeneity influences the tumor growth, progression, and responses to current therapies.


Subject(s)
Colonic Neoplasms , Colorectal Neoplasms , Humans , Colorectal Neoplasms/therapy , Colorectal Neoplasms/drug therapy , Colonic Neoplasms/pathology
2.
Neurochem Int ; 146: 105032, 2021 06.
Article in English | MEDLINE | ID: mdl-33781848

ABSTRACT

Mounting evidence suggests a major role of infectious agents in the pathogenesis of sporadic Alzheimer's disease (AD). Among them, herpes simplex virus type 1 (HSV-1) infection has emerged as a major factor in the etiology of AD. HSV-1 is able to induce some of the main alterations of the disease such as hyperphosphorylation of tau protein and accumulation of amyloid-ß peptide. Functional genomic analysis of a cell model of HSV-1 infection and oxidative stress developed in our laboratory revealed lysosomal system to be the main pathway altered, and the lysosome-associated membrane protein 2 (LAMP2) gene one of the most strongly modulated genes. The aim of this work is to study LAMP2 as an AD candidate gene and to investigate its role in the neurodegeneration induced by HSV-1 using a LAMP2 knockdown cell model. LAMP2 deficiency led to a significant reduction of viral DNA replication and formation of infectious particles. In addition, tau hyperphosphorylation and inhibition of Aß secretion induced by the virus were attenuated by the absence of LAMP2. Finally, genetic association studies revealed LAMP2 genetic variants to be associated with AD risk. In summary, our data indicate that LAMP2 could be a suitable candidate to mediate the AD-like phenotype caused by HSV-1.


Subject(s)
Alzheimer Disease/metabolism , Herpes Simplex/metabolism , Herpes Simplex/prevention & control , Herpesvirus 1, Human/metabolism , Lysosomal-Associated Membrane Protein 2/metabolism , Aged , Aged, 80 and over , Alzheimer Disease/genetics , Alzheimer Disease/virology , Animals , Cell Line, Tumor , Female , Gene Knockdown Techniques/methods , Herpes Simplex/genetics , Humans , Lysosomal-Associated Membrane Protein 2/antagonists & inhibitors , Lysosomal-Associated Membrane Protein 2/genetics , Male , Mice , Middle Aged , Neurodegenerative Diseases/genetics , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...